Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Exogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic Cells.

Zavašnik-Bergant T, Bergant Marušič M.

PLoS One. 2016 Mar 9;11(3):e0150815. doi: 10.1371/journal.pone.0150815. eCollection 2016.

2.

Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis.

Hari A, Ganguly A, Mu L, Davis SP, Stenner MD, Lam R, Munro F, Namet I, Alghamdi E, Fürstenhaupt T, Dong W, Detampel P, Shen LJ, Amrein MW, Yates RM, Shi Y.

Eur J Immunol. 2015 Feb;45(2):383-95. doi: 10.1002/eji.201445156. Epub 2014 Dec 8.

3.

Hsp90-peptide complexes stimulate antigen presentation through the class II pathway after binding scavenger receptor SREC-I.

Murshid A, Gong J, Calderwood SK.

Immunobiology. 2014 Dec;219(12):924-31. doi: 10.1016/j.imbio.2014.08.001. Epub 2014 Aug 10.

4.

Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-β/Smad signalling pathway.

Bailey JC, Iyer AK, Renukaradhya GJ, Lin Y, Nguyen H, Brutkiewicz RR.

Immunology. 2014 Dec;143(4):679-91. doi: 10.1111/imm.12353.

5.

Dendritic cells utilize the evolutionarily conserved WASH and retromer complexes to promote MHCII recycling and helper T cell priming.

Graham DB, Osborne DG, Piotrowski JT, Gomez TS, Gmyrek GB, Akilesh HM, Dani A, Billadeau DD, Swat W.

PLoS One. 2014 Jun 2;9(6):e98606. doi: 10.1371/journal.pone.0098606. eCollection 2014.

6.

Toll-like receptor 6 mediated inflammatory and functional responses of zinc oxide nanoparticles primed macrophages.

Roy R, Singh SK, Das M, Tripathi A, Dwivedi PD.

Immunology. 2014 Jul;142(3):453-64. doi: 10.1111/imm.12276.

7.

Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.

Yamasaki T, Baron GS, Suzuki A, Hasebe R, Horiuchi M.

Virology. 2014 Feb;450-451:324-35. doi: 10.1016/j.virol.2013.11.007. Epub 2014 Jan 15.

8.

Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance.

Denzin LK.

Front Immunol. 2013 Dec 17;4:465. doi: 10.3389/fimmu.2013.00465. Review.

9.

Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.

Bosch B, Berger AC, Khandelwal S, Heipertz EL, Scharf B, Santambrogio L, Roche PA.

J Biol Chem. 2013 Aug 23;288(34):24286-92. doi: 10.1074/jbc.M113.461996. Epub 2013 Jul 11.

10.

Predictor for the effect of amino acid composition on CD4+ T cell epitopes preprocessing.

Hoze E, Tsaban L, Maman Y, Louzoun Y.

J Immunol Methods. 2013 May 31;391(1-2):163-73. doi: 10.1016/j.jim.2013.02.006. Epub 2013 Feb 26.

11.

Schistosoma japonicum soluble egg antigens attenuate IFN-γ-induced MHC class II expression in RAW 264.7 macrophages.

Tang GX, Zhou HJ, Xu JW, Xu JM, Ji MJ, Wu HW, Wu GL.

PLoS One. 2012;7(11):e49234. doi: 10.1371/journal.pone.0049234. Epub 2012 Nov 13.

12.

Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.

Chornoguz O, Gapeev A, O'Neill MC, Ostrand-Rosenberg S.

Mol Cell Proteomics. 2012 Nov;11(11):1457-67. doi: 10.1074/mcp.M112.019232. Epub 2012 Aug 31.

13.

IFN-γ-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filaments.

Vardjan N, Gabrijel M, Potokar M, Svajger U, Kreft M, Jeras M, de Pablo Y, Faiz M, Pekny M, Zorec R.

J Neuroinflammation. 2012 Jun 26;9:144. doi: 10.1186/1742-2094-9-144.

14.

Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1).

Corcoran K, Jabbour M, Bhagwandin C, Deymier MJ, Theisen DL, Lybarger L.

J Biol Chem. 2011 Oct 28;286(43):37168-80. doi: 10.1074/jbc.M110.204040. Epub 2011 Sep 6.

15.

ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling.

Graham DB, Akilesh HM, Gmyrek GB, Piccio L, Gilfillan S, Sim J, Belizaire R, Carrero JA, Wang Y, Blaufuss GS, Sandoval G, Fujikawa K, Cross AH, Russell JH, Cella M, Swat W.

Blood. 2010 Oct 28;116(17):3208-18. doi: 10.1182/blood-2009-10-250415. Epub 2010 Jul 15.

16.

Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.

Porter KA, Kelley LN, George A, Harton JA, Duus KM.

PLoS One. 2010 Jun 24;5(6):e11304. doi: 10.1371/journal.pone.0011304.

17.

Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression.

Jabbour M, Campbell EM, Fares H, Lybarger L.

J Immunol. 2009 Nov 15;183(10):6500-12. doi: 10.4049/jimmunol.0901521. Epub 2009 Oct 30.

18.

Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells.

Bosch JJ, Iheagwara UK, Reid S, Srivastava MK, Wolf J, Lotem M, Ksander BR, Ostrand-Rosenberg S.

Cancer Immunol Immunother. 2010 Jan;59(1):103-12. doi: 10.1007/s00262-009-0729-0. Epub 2009 Jun 26.

Supplemental Content

Support Center